 |
Current AIDS Research Priorities
Domestic:
- Racial/ethnic disparities in HIV testing and access and utilization of treatment and services
- Improving HIV therapy by studying: ART interactions with drugs of abuse and drug abuse treatment medications, development of ART drug resistance
- Improving access, utilization, adherence, and effectiveness of HIV therapy
- Spread of HIV among drug users and their networks
- Role of non-injection drug use in facilitating HIV transmission through sexual risk behaviors (MSM and heterosexuals)
- Prevention interventions among drug users involved in the criminal justice system
- Research on adolescent development, decision-making, impulsivity
- Intervention strategies to coordinate and improve treatment and services for HIV, drug abuse, and co-occurring conditions (e.g., HCV)
- Medical consequences of HIV/AIDS, drug use, comorbid conditions, and HIV treatment
- Enhanced testing and counseling strategies
- Drug abuse, HIV, and the brain
- Genetics and proteomic studies in drug abusers and/or animal models of HIV
- Research on structural interventions to prevent HIV/AIDS transmission and/or to enhance access/utilization of treatment and services
- Support training of new AIDS researchers
International:
-
Develop prevention strategies addressing non-injection drug use such as stimulants (e.g., methamphetamine, cocaine, crack) in vulnerable populations (e.g., MSM, young women) where prevalence of HIV infection is high (e.g., Latin America)
-
Develop prevention strategies addressing HIV/injection drug use epidemics in different geographic areas (Russia, China, SE Asia, India, Eastern/Central Europe)
-
Develop regional research networks
-
Develop new methods for gathering HIV epidemiological data and tracking HIV diffusion
-
Assess role of immigration and migration in drug abuse and HIV transmission
-
Assessment of drug treatment as HIV prevention, including development of long-acting, sustainable therapies
-
Assessment of HIV/AIDS treatment as HIV prevention
-
HIV and co-infections (e.g., HCV, TB)
|
|
|
